š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This is a Phase Ib study in healthy adults (18-70 years) to evaluate the sa...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2012-08
Trial ID
NCT01676402
Treatments Being Tested
The aim of the study was to assess the immunogenicity and safety of Fluzone...
Status
Completed
Location
Sanofi Pasteur Investigational Site 002
Start Date
2015-06-17
Trial ID
NCT03546192
Treatments Being Tested
A Phase 3, randomized, observer-blinded, active-controlled trial to evaluat...
Status
Completed
Location
US135
Start Date
2019-10-14
Trial ID
NCT04120194
Treatments Being Tested
This is one project of a larger ongoing study related to the immune system'...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2019-10-08
Trial ID
NCT03898986
Treatments Being Tested
This pilot research trial studies the antibody response to high-dose season...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2017-10-17
Trial ID
NCT04484532
Treatments Being Tested
This prespecified analysis will pool the datasets from two pragmatic random...
Status
Completed
Location
Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte
Start Date
2025-05-31
Trial ID
NCT06506812
Treatments Being Tested
To describe the safety of the 2004-2005 pediatric formulation of the inacti...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00831675
The primary objective of the study was to provide sera (collected from part...
Status
Completed
Location
Investigational Site Number 8400002
Start Date
2019-09-30
Trial ID
NCT04109222
This was a Phase 1/2, randomized, observer-blinded, active-controlled trial...
Status
Completed
Location
Research Site US108
Start Date
2017-09-18
Trial ID
NCT03293498
Treatments Being Tested
Primary Objective: To demonstrate the superior relative effectiveness of Q...
Status
Terminated
Location
Investigational Site Number 2469999
Start Date
2019-11-04
Trial ID
NCT04137887